hydroxyurea and glutamine

hydroxyurea has been researched along with glutamine in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19902 (10.53)18.7374
1990's0 (0.00)18.2507
2000's1 (5.26)29.6817
2010's9 (47.37)24.3611
2020's7 (36.84)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Pardee, AB1
Dean, A; Erard, F; Schechter, AN1
Ansari, J; Gavins, FNE; Moufarrej, YE; Pawlinski, R1
Quinn, CT1
Bellevue, R; Blake, OA; Gordeuk, VR; Guillaume, E; Hsu, LL; Kanter, J; Lanzkron, S; Lasky, JL; Miller, ST; Neumayr, LD; New, TN; Niihara, Y; Osunkwo, I; Panosyan, EH; Razon, RL; Sadanandan, S; Sarnaik, S; Sieger, L; Smith, WR; Stark, CW; Tran, LT; Vichinsky, EP; Viswanathan, K1
Ataga, KI1
Hoppe, C; Neumayr, L1
Carden, MA; Little, J1
Howell, CM; Monus, T1
Gordeuk, VR; Han, J; Saraf, SL1
Hehre, RJ1
Rungkitwattanakul, D; Singh, D; Weaver, SB1
Fasipe, TA; Kavanagh, PL; Wun, T1
Lee, MT; Ogu, UO1
Ataga, KI; Desai, PC; Rai, P1
Jonassaint, CR; Kane-Gill, SL; Newman, TV; Novelli, EM; Suh, K; Yang, J1

Reviews

12 review(s) available for hydroxyurea and glutamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.
    Expert review of hematology, 2018, Volume: 11, Issue:1

    Topics: Anemia, Sickle Cell; Antisickling Agents; Cell Communication; Cerebrovascular Disorders; Disease Progression; Glutamine; Hemoglobins; Humans; Hydroxyurea; Inflammation; Mutation; Neutrophils; Quality of Life

2018
l-Glutamine for sickle cell anemia: more questions than answers.
    Blood, 2018, 08-16, Volume: 132, Issue:7

    Topics: Adolescent; Adult; Anemia, Sickle Cell; Child; Child, Preschool; Drug Approval; Female; Glutamine; Humans; Hydroxyurea; Male; United States; United States Food and Drug Administration

2018
Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.
    Hematology/oncology clinics of North America, 2019, Volume: 33, Issue:3

    Topics: Anemia, Sickle Cell; Antisickling Agents; Child; Clinical Trials as Topic; Erythrocyte Transfusion; Glutamine; Humans; Hydroxyurea; Monitoring, Physiologic; Stem Cell Transplantation

2019
Emerging disease-modifying therapies for sickle cell disease.
    Haematologica, 2019, Volume: 104, Issue:9

    Topics: Anemia, Sickle Cell; Antioxidants; Antisickling Agents; Blood Coagulation; Clinical Trials as Topic; Drug Approval; Erythrocytes; Fetal Hemoglobin; Glutamine; Hematopoietic Stem Cell Transplantation; Hemoglobin, Sickle; Humans; Hydroxyurea; Inflammation; Platelet Activation; Polymers; United States; United States Food and Drug Administration

2019
Current and emerging treatments for sickle cell disease.
    JAAPA : official journal of the American Academy of Physician Assistants, 2019, Volume: 32, Issue:9

    Topics: Acute Chest Syndrome; Acute Disease; Analgesics, Opioid; Anemia, Sickle Cell; Anti-Bacterial Agents; Antisickling Agents; Chronic Disease; Disease Progression; Erythrocyte Transfusion; Fluid Therapy; Genetic Therapy; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infant, Newborn; Infection Control; Infections; Mesenteric Ischemia; Neonatal Screening; Oxygen Inhalation Therapy; Pain Management; Patient Education as Topic; Pneumococcal Infections; Pneumococcal Vaccines; Stroke

2019
Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease.
    Pharmacotherapy, 2020, Volume: 40, Issue:6

    Topics: Anemia, Sickle Cell; Animals; Antibodies, Monoclonal, Humanized; Glutamine; Humans; Hydroxyurea; P-Selectin; Pain; Randomized Controlled Trials as Topic

2020
Managing patients with sickle cell disease in primary care.
    JAAPA : official journal of the American Academy of Physician Assistants, 2020, Volume: 33, Issue:10

    Topics: Administration, Oral; Anemia, Sickle Cell; Antibodies, Monoclonal, Humanized; Antisickling Agents; Blood Transfusion; Evidence-Based Medicine; Female; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Iodine Isotopes; Maintenance Chemotherapy; Male; Monitoring, Physiologic; Practice Guidelines as Topic; Primary Health Care

2020
Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell Disease.
    Journal of pharmacy practice, 2023, Volume: 36, Issue:1

    Topics: Adult; Anemia, Sickle Cell; Glutamine; Hospitalization; Humans; Hydroxyurea

2023
Sickle Cell Disease: A Review.
    JAMA, 2022, 07-05, Volume: 328, Issue:1

    Topics: Adult; Anemia, Sickle Cell; Antibodies, Monoclonal, Humanized; Antisickling Agents; Benzaldehydes; Child; Glutamine; Hematologic Agents; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infant, Newborn; Neonatal Screening; Pain; Pyrazines; Pyrazoles; Transition to Adult Care; United States

2022
Sickle cell disease in the new era: advances in drug treatment.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2022, Volume: 61, Issue:5

    Topics: Anemia, Sickle Cell; Fetal Hemoglobin; Glutamine; Hemoglobin, Sickle; Hemoglobins; Humans; Hydroxyurea; Nitric Oxide; Oxidants; Oxygen; United States

2022
The Evolving Landscape of Drug Therapies for Sickle Cell Disease.
    Hematology/oncology clinics of North America, 2022, Volume: 36, Issue:6

    Topics: Anemia, Sickle Cell; Genetic Therapy; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea

2022

Trials

1 trial(s) available for hydroxyurea and glutamine

ArticleYear
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
    The New England journal of medicine, 2018, Jul-19, Volume: 379, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; beta-Thalassemia; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Glutamine; Humans; Hydroxyurea; Intention to Treat Analysis; Male; Middle Aged; Pain; Pain Management; Young Adult

2018

Other Studies

6 other study(ies) available for hydroxyurea and glutamine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A restriction point for control of normal animal cell proliferation.
    Proceedings of the National Academy of Sciences of the United States of America, 1974, Volume: 71, Issue:4

    Topics: Animals; Autoradiography; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Colchicine; Cricetinae; Culture Media; DNA; DNA Replication; Glutamine; Hydroxyurea; Isoleucine; Kidney; Kinetics; Mitosis; Thymidine; Tritium

1974
Inhibitors of cell division reversibly modify hemoglobin concentration in human erythroleukemia K562 cells.
    Blood, 1981, Volume: 58, Issue:6

    Topics: Cell Transformation, Neoplastic; Culture Media; Glutamine; Hemin; Hemoglobins; Humans; Hydroxyurea; Isoelectric Focusing; Leukemia, Erythroblastic, Acute; Time Factors

1981
New and experimental agents for sickle cell disease.
    Clinical advances in hematology & oncology : H&O, 2018, Volume: 16, Issue:7

    Topics: Anemia, Sickle Cell; Antisickling Agents; Combined Modality Therapy; Drug Discovery; Erythrocyte Transfusion; Glutamine; Humans; Hydroxyurea

2018
Use of Disease-Modifying Treatments in Patients With Sickle Cell Disease.
    JAMA network open, 2023, Nov-01, Volume: 6, Issue:11

    Topics: Acute Chest Syndrome; Adult; Anemia, Sickle Cell; Child; Cross-Sectional Studies; Female; Glutamine; Humans; Hydroxyurea; Inpatients; Male

2023
chemdatabank.com